Cidara Therapeutics (CDTX) Misses Q3 EPS by 310c
Tweet
Share
E-mailGet Alerts CDTX Hot Sheet
Join SI Premium – FREE
Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($3.10).
For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- Barclays Starts Centrus Energy Corp. (LEU) at Equalweight
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
